Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026
Treatment of vitamin B12 deficiency is the only indication for prescribing of hydroxocobalamin or cyanocobalamin in primary care
Uses : Ideal for B12 injections where the typical dosage ranges from 0.5 ml to 1 ml
This is critical for longitudinal in-vitro assays where repeated dosing from the same reconstituted vial is required
Waddingham W, Kamran U, Kumar B, Trudgill NJ, Tsiamoulos ZP, Banks M
US$ 25.62
US$ 21.42
US$ 25.43
